Wordt geladen...
Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial
BACKGROUND: The CRASH-3 trial hypothesised that timely tranexamic acid (TXA) treatment might reduce deaths from intracranial bleeding after traumatic brain injury (TBI). To explore the mechanism of action of TXA in TBI, we examined the timing of its effect on death. METHODS: The CRASH-3 trial random...
Bewaard in:
| Gepubliceerd in: | Crit Care |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7657351/ https://ncbi.nlm.nih.gov/pubmed/33172504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03243-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|